Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus

This article presents the consensus of Belgian MS specialists and nephrologists on the practicalities of diagnosis, management, and treatment of alemtuzumab-associated ren al adverse events based on good clinical practice.
Source: Acta Neurologica Belgica - Category: Neurology Source Type: research